FDA Adverse Event Injury Summary report: N

CONTEGRA

MDR report key: 2946069 · Received February 6, 2013

Report

Report Number
2025587-2013-00013
Event Type
Injury
Date Received
February 6, 2013
Date of Event
February 23, 2011
Report Date
September 16, 2011
Manufacturer
HEART VALVES SANTA ANA
Product Code
MWH
PMA / PMN Number
H020003
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS REPORT WAS ORIGINALLY SUBMITTED ON (B)(4) 2013 BUT DUE TO A FDA OUTAGE, THE SUBMISSION WAS UNSUCCESSFUL. THUS, THE REPORT IS BEING RESUBMITTED ON (B)(4) 2013. PRODUCT ANALYSIS: THE DEVICE REMAINS IMPLANTED AND THEREFORE, HAS NOT BEEN RETURNED TO MEDTRONIC FOR EVALUATION. CONCLUSION: THE DEVICE HISTORY RECORD WAS UNABLE TO BE REVIEWED AS THE SERIAL NUMBER OF THE DEVICE WAS NOT PROVIDED. WITHOUT THE RETURN OF THE PRODUCT, NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATION. (B)(6). (B)(4).

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION THAT AN UNKNOWN DURATION FOLLOWING THE IMPLANT OF THIS PULMONARY VALVED CONDUIT, STENOSIS AND REGURGITATION WERE NOTED. A BIOPROSTHETIC TRANSCATHETER VALVE WAS IMPLANTED WITHIN THE CONDUIT TO RESOLVE THE ISSUE. NO ADVERSE PATIENT EFFECTS HAVE BEEN REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
50111 CONTEGRA CONDUIT,VALVED,PULMONIC MWH HEART VALVES SANTA ANA 200S

Patients

Seq Age Sex Outcome Treatment
1 00013 YR Required Intervention